Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors
暂无分享，去创建一个
[1] M. Gleave,et al. Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model , 2012, British Journal of Cancer.
[2] H. Watari,et al. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel , 2011, Journal of experimental & clinical cancer research : CR.
[3] M. Gariboldi,et al. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. , 2008, Endocrine-related cancer.
[4] M. Gleave,et al. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model. , 2005, Oncology reports.
[5] M. Gleave,et al. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer , 2005, World Journal of Urology.
[6] G. Sheu,et al. Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells , 2011, Cancer Chemotherapy and Pharmacology.